Aurora Cannabis (ACB) Retained Earnings (2018 - 2026)
Aurora Cannabis (ACB) posted quarterly Retained Earnings of -$4.7 billion for Q1 2026, down 4340.03% year-on-year from $110.8 million in Q1 2025, and down 2.28% on a QoQ basis from -$4.6 billion in Q4 2025.
Aurora Cannabis (ACB) Retained Earnings (2018 - 2026) Analysis & Trends
Aurora Cannabis (ACB) has reported Retained Earnings for 9 consecutive years, with -$4.7 billion the latest figure, recorded in Q1 2026.
- Quarterly Retained Earnings fell 4340.03% year-over-year to -$4.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.7 billion (down 4340.03% YoY) and the FY2026 annual result came in at -$4.7 billion, down 4176.23% from the prior year.
- Retained Earnings declined to -$4.7 billion in Q1 2026 per ACB's latest filing, from -$4.6 billion in the prior quarter.
- Over the last five years, Retained Earnings for ACB reached as high as $120.5 million in Q1 2024 and fell as low as -$4.7 billion in Q2 2022.
- A 5-year average of -$4.1 billion and a median of -$4.7 billion in 2025 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2024 — Retained Earnings jumped 102.59% — and 2026, when it tumbled 4340.03%.
- Year by year, Retained Earnings stood at -$4.6 billion in 2022, then decreased by 2.13% to -$4.7 billion in 2023, then gained by 2.69% to -$4.6 billion in 2024, then declined by 0.9% to -$4.6 billion in 2025, then slipped by 2.28% to -$4.7 billion in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$4.7 billion, -$4.6 billion, and -$4.7 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Aurora Cannabis | 1.11 Bn | 1.03 Bn | 21.72 Mn | -4.70 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.70 Bn |
| Dec 31, 2025 | -4.59 Bn |
| Sep 30, 2025 | -4.65 Bn |
| Jun 30, 2025 | -4.61 Bn |
| Mar 31, 2025 | 110.79 Mn |
| Dec 31, 2024 | -4.55 Bn |
| Sep 30, 2024 | -4.68 Bn |
| Jun 30, 2024 | -4.66 Bn |
| Mar 31, 2024 | 120.48 Mn |
| Dec 31, 2023 | -4.68 Bn |
| Sep 30, 2023 | -4.73 Bn |
| Jun 30, 2023 | -4.71 Bn |
| Mar 31, 2023 | -4.65 Bn |
| Dec 31, 2022 | -4.58 Bn |
| Sep 30, 2022 | -4.72 Bn |
| Jun 30, 2022 | -4.73 Bn |
| Mar 31, 2022 | -4.28 Bn |
| Dec 31, 2021 | -3.50 Bn |
| Sep 30, 2021 | -3.44 Bn |
| Jun 30, 2021 | 115.11 Mn |